hackint0sh/New-Dataset huggingface dataset:
Misoprostol, a prostaglandin E1 analogue, can reduce bleeding during myomectomy by promoting myometrial contractions and reducing uterine artery blood flow. It can be administered via multiple routes, with rectal administration showing advantages in maintaining high plasma concentrations during surgery. Studies have investigated the effectiveness of single preoperative rectal doses of misoprostol versus preoperative oxytocin in reducing bleeding during abdominal myomectomy. conditions: Myoma;Uterus studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 56 type: ESTIMATED name: Misoprostol 200mcg Tab name: Oxytocin measure: intra-operative blood loss measure: blood transfusion measure: post-operative Hb measure: total surgery time sex: FEMALE minimumAge: 20 Years maximumAge: 48 Years stdAges: ADULT facility: faculty of medicine, Kasr el ainy hospital, Cairo university status: RECRUITING city: Cairo zip: 11562 country: Egypt name: Mohammad A Taymour, MD role: CONTACT phone: 01555761995 email: Mohammadtaymour@gmail.com name: Waleed M Elkhyat role: CONTACT phone: 01005135542 email: Waleed_elkhyat@yahoo.com lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06325488 id: H-23035668 briefTitle: Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease acronym: FORTIFY overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-03-01 date: 2025-06-01 date: 2024-03-22 date: 2024-03-22 name: Caroline Michaela Kistorp class: OTHER name: Sanofi briefSummary: The overall objective of this study is to investigate Fabry-associated renal organ involvement by using a novel magnetic resonance imaging (MRI) approach, focusing on changes in renal oxygen levels by blood oxygenation-level dependent (BOLD) imaging. Furthermore, to correlate renal oxygenation to the phenotypic presentation of patients with Fabry-associated nephropathy regarding circulating and imaging-derived biomarkers of kidney inflammation, fibrosis and injury as compared with healthy age- and sex-matched controls.
2) Using an extensive, in-depth biomarker blood panel to investigate the pathological pathways associated with Fabry disease and Fabry-associated nephropathy. conditions: Fabry Disease conditions: Chronic Kidney Diseases studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: PROSPECTIVE count: 60 type: ESTIMATED measure: Renal hypoxia (Fabry patients according to renal impairment) measure: Renal hypoxia (Fabry patient vs controls) measure: Renal cortical perfusion (Fabry vs. controls) measure: Renal medullar perfusion (Fabry vs. controls) measure: Renal inflammation (Fabry vs. controls) measure: Renal fibrosis (Fabry vs. controls) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Rigshospitalet city: Copenhagen zip: 2100 country: Denmark lat: 55.67594 lon: 12.56553 typeAbbrev: Prot hasProtocol: True hasSap: False hasIcf: False label: Study Protocol date: 2023-07-14 uploadDate: 2023-09-18T03:04 filename: Prot_000.pdf size: 808560 typeAbbrev: SAP hasProtocol: False hasSap: True hasIcf: False label: Statistical Analysis Plan date: 2024-01-14 uploadDate: 2024-02-21T07:14 filename: SAP_001.pdf size: 1460496 hasResults: False
nctId: NCT06325475 id: B.30.2.ATA.0.01.00/530 briefTitle: Comparison of Patients' Postpartum Recovery Using ObsQoR-10 Score in Pregnant Women in Vaginal Delivery With and Without Neuraxial Labor Analgesia overallStatus: RECRUITING date: 2024-03-26 date: 2024-07-26 date: 2024-08-26 date: 2024-03-22 date: 2024-03-22 name: Ataturk University class: OTHER briefSummary: The aim of this study was to compare the postpartum recovery of pregnant women who had vaginal delivery with and without neuraxial labor analgesia using the ObsQoR-10 scoring system. conditions: Analgesia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: labor with neuraxial labor analgesia name: labour without noroaxial labor analgesia measure: ObsQoR-10 scores of postpartum patients sex: FEMALE minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: Atatürk University status: RECRUITING city: Erzurum country: Turkey name: Ayşenur Dostbil role: CONTACT phone: +905333677796 email: adostbil@hotmail.com lat: 39.90861 lon: 41.27694 hasResults: False
nctId: NCT06325462 id: E2232/2023 briefTitle: The Influence of Anesthetic Technique on Cerebral Oxygenation During Spinal Surgery overallStatus: RECRUITING date: 2024-02-10 date: 2024-08 date: 2024-12 date: 2024-03-22 date: 2024-03-22 name: Prince Sultan Military Medical City class: OTHER briefSummary: Postural changes during anesthesia can lead to decreased cerebral blood flow and oxygenation, especially when moving from a supine to a prone position. This is particularly relevant during spinal surgery with controlled hypotension. Cerebral oximetry, monitored in the frontal cortex using an O3 sensor, is a noninvasive and continuous method to investigate the impact of anesthetic techniques on cerebral oxygenation in such scenarios. conditions: Cerebral Oxygenation studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 54 type: ESTIMATED name: sensors of regional cerebral oxygen saturation (O3 regional oximeter, Masimo Corp, Irvine, CA) FDA Reg No. 3011353843 measure: regional cerebral oxygen saturation sex: ALL minimumAge: 18 Years maximumAge: 68 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Prince Sultan Military Medical City status: RECRUITING city: Riyadh zip: 11159 country: Saudi Arabia name: Muteb AlOtaibi, M.D. role: CONTACT phone: 00966544793370 email: muteb612@gmail.com name: Rashid Al-Otaibi, M.D. role: SUB_INVESTIGATOR name: Osama Shalaan, M.D. role: SUB_INVESTIGATOR name: Muteb Al-Otaibi, M.D. role: SUB_INVESTIGATOR name: Majid Al-Sherif role: SUB_INVESTIGATOR lat: 24.68773 lon: 46.72185 hasResults: False
nctId: NCT06325449 id: 5323 briefTitle: Correlating Improvement in PCOS Symptoms to the Percentage of Body Weight Lost in Females Also Living With Obesity acronym: FLOWERS-PCOS overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-01-01 date: 2026-01-01 date: 2024-03-22 date: 2024-03-22 name: Ottawa Hospital Research Institute class: OTHER name: LEAF Weight Loss Clinic briefSummary: The goal of this clinical trial is to study the effects of a intensive weight loss program (STREAM) in patients living with PCOS. The main questions the investigators aim to answer are: how much weight will these patients lose over a 24-week program, and what other health markers (ie., insulin sensitivity) will improve and by how much?
* fill out a Quality of Life questionnaire at regular intervals conditions: Polycystic Ovary Syndrome conditions: Obesity studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Clinic patients with PCOS will be recruited to participate in a 24-week weight loss program. They will all receive the program. There is no control group. primaryPurpose: TREATMENT masking: NONE count: 20 type: ESTIMATED name: STREAM program measure: Weight loss measure: Change in Endocrine parameters (EP) as measure by blood test measure: Change in insulin sensitivity (IS) as measure by blood test measure: Change in Lipid profile (LP) as measure by blood test measure: Change in liver enzyme profile (LEP) as measure by blood test measure: Change in Menstrual Cyclicity measure: Quality of Life (QoL) Scale sex: FEMALE minimumAge: 18 Years maximumAge: 99 Years stdAges: ADULT stdAges: OLDER_ADULT facility: LEAF Weight Management Clinic city: Ottawa state: Ontario zip: K1J9L3 country: Canada name: Judy Shiau, MD role: CONTACT phone: 613-701-1222 email: dr.shiau@leafwmc.ca name: Julie Laroche role: CONTACT phone: 613-701-1222 email: info@leafwmc.ca lat: 45.41117 lon: -75.69812 hasResults: False
nctId: NCT06325436 id: scores in variceal bleeding briefTitle: Objective Scores in Variceal Bleeding overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-05-01 date: 2026-01-01 date: 2024-03-22 date: 2024-03-22 name: Assiut University class: OTHER briefSummary: To assess the prognostic performance of the ALBI associated scores (ALBI, PALBI and INR-ALBI score) and new MELD .3 in predicting the short-term outcomes (early re-bleeding and early mortality) of patients with cirrhosis presenting with acute variceal bleeding, comparable to the CTP and MELD and MELD Na scores. conditions: Variceal Hemorrhage studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 85 type: ESTIMATED measure: assess the prognostic performance of the ALBI_associated scores and new MELD .3 in predicting the short-term outcomes of patients with cirrhosis presenting with acute variceal bleeding. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06325423 id: response to NAC in MIBC briefTitle: Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-06 date: 2027-06 date: 2024-03-22 date: 2024-03-26 name: Assiut University class: OTHER briefSummary: Bladder cancer (BC) is the 10th most commonly diagnosed cancer worldwide and the second most common cancer among Egyptian males.
The 5-year cancer-specific survival for responders to NAC is 90%, in contrast to 30-40% for those not obtaining an objective response. Drawbacks of NAC are disappointing delay of surgery in non-responders and the potential toxicity. So, predictors of response to NAC are necessary to identify patients who may achieve pathologic complete response and will benefit from BP, and the others who may not respond to NAC and spare them NAC toxicity and RC delay.
On the other hand, immune cells that are present in the TME play a major role in slowing down tumor progression. CD8+T lymphocytes play a central role in immune-mediated control of cancer . Also, they have been found to be a prognostic tool for advanced BC. conditions: Muscle-Invasive Bladder Carcinoma studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: OTHER count: 50 type: ESTIMATED name: neoadjuvant chemotherapy measure: Evaluation of the expression of NETs and CD8 in paraffin-embedded TUR biopsies measure: - Response to platinum-based chemotherapy in localized MIBC in relation to: NETs expression, CD8 expression, NET/CD8 ratio and baseline clinicopathological features measure: Local recurrence-free survival (RFS) sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06325410 id: #11279-20-11-2023 briefTitle: Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience overallStatus: COMPLETED date: 2013-01 date: 2022-12 date: 2022-12 date: 2024-03-22 date: 2024-03-22 name: Zagazig University class: OTHER_GOV briefSummary: over the past decade colon cancer has emerged as the second most deadly and the third most common type of cancer in the world with increasing incidence in Egypt due to life style and diet change. some research showed relation between colon cancer recurrence and advanced tumor staging. To investigators knowledge, this is the first time to be done in Zagazig University.
Data was collected from records in a retrospective cohort study conditions: Colorectal Cancer studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 200 type: ACTUAL name: resection of colorectal cancer measure: age measure: sex measure: medical disease measure: previous surgery measure: CEA measure: tumor grade measure: tumor site measure: tumor size measure: surgical margins of resected tumor measure: neoadjuvant therapy measure: adjuvant therapy measure: diet measure: occupation measure: family history measure: type of surgery(laparoscopic or open) measure: soiling by during surgery measure: hand sewen or stappled anastmosis measure: post operative complications measure: site of recurrence measure: type of resected tumor sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Zagazig University Hospitals city: Zagazig zip: 44519 country: Egypt lat: 30.58768 lon: 31.502 hasResults: False
nctId: NCT06325397 id: IIT #88313865 briefTitle: Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP) overallStatus: RECRUITING date: 2023-10-23 date: 2024-04 date: 2024-06 date: 2024-03-22 date: 2024-03-22 name: Matthew Rauen class: OTHER briefSummary: To investigate the impact of high vs low Intraocular Pressure (IOP) on the intraoperative experience for the patient and surgeon. Operating at a more physiologic IOP using Active Sentry hand piece during cataract surgery will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication conditions: Nuclear Cataract studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 75 type: ESTIMATED name: High Intraocular Pressure (IOP) name: Low Intraocular Pressure (IOP) measure: Medication Rescue measure: Physiologic Responses associated with pain/inflammation: measure: Physiologic Responses associated with pain/inflammation: measure: Surgeon Experience: Assessment on patient cooperation measure: Surgeon Experience: Surgeon intraoperative experience measure: Cost- analysis sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Wolfe Eye Clinic status: RECRUITING city: West Des Moines state: Iowa zip: 50266 country: United States name: Robyn Kohler, RN role: CONTACT phone: 515-223-8685 phoneExt: 2305 email: rkohler@wolfeclinic.com name: Hillery Joiner role: CONTACT phone: 5152238685 phoneExt: 2085 email: hjoiner@wolfeclinic.com name: Matthew Rauen, MD role: PRINCIPAL_INVESTIGATOR lat: 41.57721 lon: -93.71133 hasResults: False
nctId: NCT06325384 id: IRAS ID:1008701 briefTitle: Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care acronym: VISION-RWE overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2025-08-31 date: 2025-08-31 date: 2024-03-22 date: 2024-03-22 name: Xim Limited class: INDUSTRY name: Barts & The London NHS Trust name: Mind Over Matter Medtech Ltd name: Health Innovation Wessex briefSummary: A randomised controlled trial for comparison of real-world feasibility and clinical outcomes of two different methods of home blood pressure monitoring Participants aged 18 years or over with diagnosed and treated hypertension (including via lifestyle interventions) that is not controlled (i.e. in-clinic measurement is 140/90 mmHg or greater) will be recruited from hypertension hospital clinics conditions: Hypertension studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: DOUBLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER count: 500 type: ESTIMATED name: Lifelight name: Blood Pressure Cuff measure: Blood Pressure Measurement Non Inferiority measure: Adherance to Blood Pressure Measurement sex: ALL minimumAge: 18 Years maximumAge: 100 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06325371 id: 0028201 briefTitle: Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Derivo 2 acronym: DEDICATE overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-06-30 date: 2025-06-30 date: 2024-03-22 date: 2024-03-22 name: University of Turin, Italy class: OTHER briefSummary: This is a multicentric voluntary observational study with a retrospective evaluation of prospectively collected data concerning the treatment of visceral aneurysms with flow diversion stent Derivo Peripher and Derivo 2 (DED, Acandis GmbH) Follow-up will include clinical and radiological (CT) evaluation at least 12 months after the intervention.
The enrollment period will be of 54 months (01/01/2020-30/06/2024). Minimum sample size will be of 50 Patients. conditions: Aneurysm Abdominal conditions: Arterial Aneurysm studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: CROSS_SECTIONAL count: 50 type: ESTIMATED name: Visceral aneurysm stenting measure: Efficacy of the stenting in terms of patency and side branches measure: Efficacy of the stenting in terms of aneurysm thrombosis rate measure: Efficacy of the stenting in terms of aneurysm volume assessment measure: Safety in terms of morbidity measure: Safety in terms of mortality measure: Safety in terms of technical issues sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06325345 id: 22-5277 briefTitle: RCT of Gut-directed Hypnotherapy in Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-12-29 date: 2025-04-01 date: 2024-03-22 date: 2024-03-22 name: University Health Network, Toronto class: OTHER briefSummary: This randomized, controlled trial (RCT) will evaluate the effectiveness of gut-directed hypnotherapy for management of Irritable Bowel Syndrome (IBS) in individuals diagnosed with Ehlers-Danlos Syndromes or Generalized Hypermobility Spectrum Disorders (G-HSD). Consenting patients recruited from the Toronto General Hospital GoodHope Ehlers-Danlos Syndrome Clinic will be randomly assigned to one of two groups: (1) standard medical therapy or (2) standard medical therapy plus eight sessions of gut-directed hypnotherapy. The main questions this study will answer are:
All participants will be asked to meet with a gastroenterologist three times as part of the standard medical therapy. At each physician visit, they will undergo electrocardiogram recording and complete self-report measures of gastrointestinal symptoms, quality of life, visceral sensitivity, and emotional distress. Participants randomized to receive gut-directed hypnotherapy will also eight weekly remotely-delivered sessions of gut-directed hypnotherapy delivered by a trained behavioral therapist in between the first and second physician visit. At each session of gut-directed hypnotherapy, a voluntary, pleasant, and dream-like state of deep relaxation will be induced and suggestions made for greater relaxation, abdominal comfort, and normalization of gut function. The first session will also include 30 minutes of education on the nature of the gut-brain axis and hypnotherapy prior to hypnosis.
Researchers will compare study groups to see if participants who engaged in gut-directed hypnotherapy had greater improvement in IBS symptoms, other gastrointestinal symptoms, quality of life, visceral sensitivity, and emotional distress. Exploratory analyses will examine the relationships among heart rate variability, an index of parasympathetic nervous system activity, and study outcomes. conditions: Ehlers-Danlos Syndrome conditions: Irritable Bowel Syndrome conditions: Hypermobility Syndrome conditions: Gastrointestinal Dysfunction studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 74 type: ESTIMATED name: Gut-directed hypnotherapy name: Standard Medical Therapy measure: IBS Symptom Severity measure: Upper Gastrointestinal Symptoms measure: IBS-related Quality of Life measure: Visceral Sensitivity measure: Emotional Distress measure: Weekly Ratings of GI Health and Medication Use sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Toronto General Hospital city: Toronto state: Ontario zip: M5G 2C4 country: Canada lat: 43.70011 lon: -79.4163 hasResults: False
nctId: NCT06325332 id: RSV00080 briefTitle: BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study) acronym: BEAR overallStatus: RECRUITING date: 2024-04-01 date: 2025-04-01 date: 2025-04-01 date: 2024-03-22 date: 2024-04-08 name: Sanofi Pasteur, a Sanofi Company class: INDUSTRY briefSummary: The primary objectives of the study are: To estimate the effectiveness of nirsevimab against polymerase chain reaction (PCR)-confirmed RSV (1) lower respiratory tract (LRTD) and (2) related medical encounters.
5. To estimate the impact of nirsevimab on antibiotic prescription. conditions: Respiratory Syncytial Virus studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 33000 type: ESTIMATED name: Nirsevimab measure: Incidence of first episodes of polymerase chain reaction (PCR)-confirmed RSV with an lower respiratory tract disease (LRTD) measure: Number of medical encounters associated with the first episode of PCR-confirmed RSV with a LRTD diagnosis measure: Number of respiratory-related medical encounters measure: Number of respiratory-related medical encounters for LRTD by ICD-10 codes measure: Incidence of PCR-confirmed RSV (first occurrence of season) measure: Number of medical encounters for otitis media by ICD-10 codes measure: Number of antibiotic prescriptions by National Drug Code (NDC) codes sex: ALL minimumAge: 0 Days maximumAge: 12 Months stdAges: CHILD facility: Kaiser Permanente Northern California: Site number 0001 status: RECRUITING city: Oakland state: California zip: 94612 country: United States lat: 37.80437 lon: -122.2708 hasResults: False
nctId: NCT06325319 id: Ref. No. MA.84/261/02/1/115 briefTitle: Effect of Community Engagement Using M-Mama Champions overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-04 date: 2024-05 date: 2024-03-22 date: 2024-03-22 name: University of Dodoma class: OTHER name: Stephen Kibusi name: James Tumaini Kengia briefSummary: This study aims to determine the effectiveness of community engagement using M-MAMA Champions on awareness of Obstetric Danger Signs, Birth Preparedness, and Complication Readiness among Pregnant Women in Bahi, Dodoma. This is a community-based, cluster randomized controlled trial (cRCT) study, whereby 120 first and second-trimester pregnant women will be randomized at a ratio of 1:1 to the intervention and control groups. The intervention of sensitizing pregnant women on Obstetric danger signs, birth preparedness, and complication readiness by the empowered M-MAMA Champions to the intervention arm clusters will be done for one month, a two-hour session will be delivered every two weeks, using participatory learning and action model for women groups to test the effectiveness of M-MAMA Champions in improving literacy level of obstetric danger signs, birth preparedness and complication readiness and its practice among pregnant women.
The control arm won't receive any intervention. conditions: Obstetric Complication conditions: Woman's Role studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 120 type: ESTIMATED name: Community engagement using M-MAMA Champions to improve awareness on obstetric danger signs, bith preparedness and complication readiness among pregnant women measure: Improvement in scores from a semi-structured interviewer-administered questionnaire on awareness of obstetric danger signs among pregnant women. measure: Improvement in scores from a semi-structured interviewer-administered questionnaire of awareness of birth preparedness and complication readiness among pregnant women measure: Improvement in scores from a semi-structured interviewer-administered questionnaire on reported practice of birth preparedness and complication readiness sex: FEMALE minimumAge: 15 Years maximumAge: 49 Years stdAges: CHILD stdAges: ADULT facility: University of Dodoma city: Dodoma zip: 259 country: Tanzania name: Alex P Sanga, MSc. PH role: CONTACT phone: 0762144082 email: sanga.alex@gmail.com name: Stephen Kibusi, PhD role: CONTACT phone: 0712600966 email: skibusi@gmail.com lat: -6.17221 lon: 35.73947 hasResults: False